Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus. Stanley Erck, CEO of Novavax, has said numbers show 'dramatic demonstrations' of ability of new vaccine to develop an immune response against different strains of Covid-19. The UK vaccines taskforce has bought 60m doses of the Novavax vaccine and it will be manufactured on Teesside in the UK

Subscribe to Guardian News on YouTube ► http://bit.ly/guardianwiressub

Novavax Covid vaccine shown to be nearly 90% effective in UK trial ► https://www.theguardian.com/society/2021/jan/28/novavax-covid-vaccine-shown-to-be-nearly-90-effective-in-uk-trial

Coronavirus – latest updates ► https://www.theguardian.com/world/series/coronavirus-live/latest

See all our coronavirus coverage ► https://www.theguardian.com/world/coronavirus-outbreak

Support the Guardian ► https://support.theguardian.com/contribute

Today in Focus podcast ► https://www.theguardian.com/news/series/todayinfocus

The Guardian YouTube network:

The Guardian ► http://www.youtube.com/theguardian
Guardian Football ► http://is.gd/guardianfootball
Guardian Sport ► http://bit.ly/GDNsport
Guardian Culture ► http://is.gd/guardianculture